258 related articles for article (PubMed ID: 20570202)
1. [High dose for prostate irradiation with image guided radiotherapy: contribution of intensity modulation arctherapy].
Jouyaux F; De Crevoisier R; Manens JP; Bellec J; Cazoulat G; Haigron P; Chira C; Le Prisé E; Lafond C
Cancer Radiother; 2010 Dec; 14(8):679-89. PubMed ID: 20570202
[TBL] [Abstract][Full Text] [Related]
2. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
Latorzeff I; Mazurier J; Boutry C; Dudouet P; Richaud P; de Crevoisier R
Cancer Radiother; 2010 Oct; 14(6-7):479-87. PubMed ID: 20797889
[TBL] [Abstract][Full Text] [Related]
3. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment volumes and techniques in prostate cancer radiation therapy.
Lee CT; Dong L; Ahamad AW; Choi H; Cheung R; Lee AK; Horne DF; Breaux AJ; Kuban DA
Am J Clin Oncol; 2005 Dec; 28(6):618-25. PubMed ID: 16317275
[TBL] [Abstract][Full Text] [Related]
5. Biological optimization in volumetric modulated arc radiotherapy for prostate carcinoma.
Mihaylov IB; Fatyga M; Bzdusek K; Gardner K; Moros EG
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1292-8. PubMed ID: 21570214
[TBL] [Abstract][Full Text] [Related]
6. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
[TBL] [Abstract][Full Text] [Related]
7. Intensity modulated neutron radiotherapy for the treatment of adenocarcinoma of the prostate.
Santanam L; He T; Yudelev M; Forman JD; Orton CG; Heuvel FV; Maughan RL; Burmeister J
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1546-56. PubMed ID: 17674984
[TBL] [Abstract][Full Text] [Related]
8. Australia-wide comparison of intensity modulated radiation therapy prostate plans.
Skala M; Holloway L; Bailey M; Kneebone A
Australas Radiol; 2005 Jun; 49(3):222-9. PubMed ID: 15932465
[TBL] [Abstract][Full Text] [Related]
9. Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer.
Tao Y; Lefkopoulos D; Ibrahima D; Bridier A; Polizzi Mdel P; Wibault P; De Crevoisier R; Arriagada R; Bourhis J
Acta Oncol; 2008; 47(3):442-50. PubMed ID: 17906985
[TBL] [Abstract][Full Text] [Related]
10. A method for the prediction of late organ-at-risk toxicity after radiotherapy of the prostate using equivalent uniform dose.
Fleming C; Kelly C; Thirion P; Fitzpatrick K; Armstrong J
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):608-13. PubMed ID: 20934261
[TBL] [Abstract][Full Text] [Related]
11. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
[TBL] [Abstract][Full Text] [Related]
12. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer.
Price RA; Hannoun-Levi JM; Horwitz E; Buyyounouski M; Ruth KJ; Ma CM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):583-92. PubMed ID: 16966000
[TBL] [Abstract][Full Text] [Related]
13. A VMAT planning solution for prostate patients using a commercial treatment planning system.
Boylan CJ; Golby C; Rowbottom CG
Phys Med Biol; 2010 Jul; 55(14):N395-404. PubMed ID: 20601771
[TBL] [Abstract][Full Text] [Related]
14. Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs).
Jereczek-Fossa BA; Cattani F; D'Onofrio A; Cambria R; Kowalczyk A; Corallo A; Vavassori A; Zerini D; Ivaldi GB; DeCobelli O; Orecchia R
Radiother Oncol; 2006 Dec; 81(3):294-302. PubMed ID: 17113670
[TBL] [Abstract][Full Text] [Related]
15. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
Murray LJ; Lilley J; Thompson CM; Cosgrove V; Mason J; Sykes J; Franks K; Sebag-Montefiore D; Henry AM
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):406-15. PubMed ID: 24685447
[TBL] [Abstract][Full Text] [Related]
16. The use of photon beams of a flattening filter-free linear accelerator for hypofractionated volumetric modulated arc therapy in localized prostate cancer.
Zwahlen DR; Lang S; Hrbacek J; Glanzmann C; Kloeck S; Najafi Y; Streller T; Studer G; Zaugg K; Luetolf UM
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1655-60. PubMed ID: 22572080
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of treatment planning by carbon ion radiotherapy and by intensity-modulated radiotherapy for prostatic adenocarcinoma].
Wang WH; Tsuji H; Ishikawa H; Tsujii H; Kamada T; Mizoe J; Li YX
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):836-9. PubMed ID: 17416005
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment.
Quan EM; Li X; Li Y; Wang X; Kudchadker RJ; Johnson JL; Kuban DA; Lee AK; Zhang X
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1169-78. PubMed ID: 22704703
[TBL] [Abstract][Full Text] [Related]
19. Does pelvic lymph nodes irradiation using intensity modulated radiation therapy increase rectal and bladder toxicities in patients with prostate carcinoma?
Garipagaoglu M; Sengoz M; Senkesen O; Ozan Göksel E; Tezcanli E; Kucucuk H; Aslay I
J BUON; 2010; 15(4):668-73. PubMed ID: 21229627
[TBL] [Abstract][Full Text] [Related]
20. Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.
Vassis S; Nöldeke B; Christiansen H; von Klot CA; Merten R
Strahlenther Onkol; 2020 Jul; 196(7):598-607. PubMed ID: 32040691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
